Mandy Van Brakel
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma.
Journal: International journal of nanomedicine
Published: August 16, 2025
Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in blood.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 31, 2025
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC after Immune Checkpoint Blockade.
Journal: Cancer immunology research
Published: May 27, 2025
CXCL10 Secreted by Pericytes Mediates TNFα-Induced Vascular Leakage in Tumors and Enhances Extravasation of Nanoparticle-Based Chemotherapeutics.
Journal: Cancer research
Published: October 18, 2024
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.
Journal: Cancer discovery
Published: February 02, 2024
Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 27, 2022
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: October 08, 2021
Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy.
Journal: Cancers
Published: January 27, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.
Journal: Journal for immunotherapy of cancer
Published: November 15, 2020
T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope.
Journal: Cancers
Published: April 12, 2020
Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients.
Journal: Journal of neuro-oncology
Published: June 17, 2019
CD45RA+CCR7- CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab.
Journal: Journal for immunotherapy of cancer
Published: September 19, 2018
Last Updated: 09/26/2026